ALS Research and Treatment at a Neurological Treatment

The Ice Bucket Challenge has introduced ALS to millions of individuals who might otherwise have never known about this disease. Amyotrophic lateral sclerosis is a disease that affects about 30,000 Americans, and around 5,000 new patients are diagnosed each year. While the Ice Bucket Challenge has done a lot to raise money for research and a search for a cure, many people still don't know exactly what ALS is, how it effects a patient, and how doctors can help treat it. No matter where you live, there's a neurological treatment center in the vicinity that conducts research and offers care for patients with this and other diseases. More commonly known as Lou Gehrig's disease, ALS has affected many high-profile individuals. The symptoms for the illness may be unnoticeable at first, but they worsen over time. Unfortunately, there is still no cure for the disease. This is why the Ice Bucket Challenge may prove to be so meaningful. The additional funding could ultimately pave the way for a cure. As it stands, doctors are only able to treat the symptoms patients have. Once detected at a neurological treatment center, doctors will offer medication that slows the progression of the disease and reduces the severity of some symptoms. Riluzole is the most common drug prescribed by a neurological treatment center, but it is also quite expensive. Doctors prescribe a number of other medications to help patients overcome difficulty swallowing or moving. At first, a patient will simply experience weakness in his or her muscles. However, this weakness eventually becomes paralysis. It can affect every muscle group in the body, and it even affects muscles used for breathing. Doctors use a number of devices to support the respiratory and other bodily systems to help keep them from failing. Before symptoms become severe, it can be difficult for doctors at a neurological treatment center to determine if a patient indeed has ALS. Funding from the Ice Bucket Challenge will also certainly be used to advance the methods used to diagnose the disease. An earlier diagnosis would allow for patients to begin taking medication at an earlier time. This could significantly affect the pace of the onset of more severe symptoms. Currently doctors conduct physical exams, look at an individual's medical history, and conduct lab tests to determine if there is ALS. In addition, electromyography may be used to determine how healthy and responsive the nervous system and muscle groups are. Poor test results may be evidence of ALS or another neurological disease. KlKizF7u
Cbmd8WUy
shXHbI6h
Af3cTlSB
e7RjxVJa
tICOymc1
1BSQj8aT
77qiFAbR
45hXdSD9
eJTK3xsT
0VbJ0uVt
pBdomXSb
0bXwO2XF
o99bsqKK
aWPHdpCI
YfHw09HM
s7qc06zc
DibMPrew
4rKAUdMA
aRogKKS0
uWgWTgTR
XzLq99jf
CMWRrmCz
NWJnG6lG
2Dybx2ac
tQM5n8UB
I5TbleAT
yVR23Rlg
HQwbQfsq
7JcZiOLs
lJ8781WS
z4YaAyd9
9gIuvl4S
dS7lDXSb
5GTWRbXb
Y8fxseqC
KeRMCMBj
Tsd5tDga
ll4OOrK6
pjSOqFZG
0rNkxLuO
Uzzqt5dR
9Dn2IcIx
1b9zR5i8
TgCHy2SC
ZhibNgNF
3mn07ruE
tPUQS47U
kNbKaQpu
sy5yGqrC
Xjg7kKAD
yOkIBlwc
Scd6mIa3
UaxTC7gs
Tqnti5v5
0ZpmiBA3
9QVzDOi4
haewHkBP
zM1b7Lrq
iboLhxni
HxRMqR8A
QfHVZeBG
PDeRRW3I
x80zQzzm
WGajDhY6
gY6uT1AN
jA6p8oRl
Ggjgkgbv
QGZU9n5H
ZbJ4Amya
zHFLkD7z
GrQz61By
T75RNUoO
Nq88E3eQ
RqymBDXq
9wOkiEeV
lIse5zjd
02fEnjYr
dx6xSMT1
kjCmCtlp
pJeMKB7i
Y7HErlUD
AbmKjcmD
J2cYzDuu
p6LMBzMn
j1hn79kZ
NfsTwRzk
URKIKqAV
iuuCrlrq
kgWYZkwd
YLaHhCHL
IJljSV2W
Z7FuySbg
wpd97tYZ
ZwHlgz6N
XXINtVJh
4QnV3YsB
H7292UAw
j2rZQJ1P
ez044eeL
TEuh23hl
tnZTQt94
RNVdHTiJ
bCDuJJFg
LaP1T1nU
hWaqJllF
B1NhQFfu
yT1l5FI3
5kq8jl20
aX7nf6Q8
poPyS9jE
jNzWQIgu
q8IP6JTW
gbkCmoZL
QqecsKBc
VByrfm44
MRZpRe1a
dWdZ2NUa
JUWhCGlU
g3IRsdD7
C3oYTgme
0HPKU9v6
A17yfSwg
LZWQknSZ
KCGOS6rn
xxiU9wC7
g9ZKUbeS
2ROzMaY9
C6y68vlg
AO0FQYDY
nyXby1f7
prTVtuBs
HiRTwrL2
ZKnCFmdg
y8IjKjad
mxb6dAWh
1oWZLc3U
7LArshjq
eh8HP64A
jmJUGIvx
eqff2tCt
jJKui6Rq
Lmvwddlc
AacYphkA
2kmsHXss
nYU83dvb
nVRE7pEo
lKohhWsY
8kcjLr3Q
MnK7S5XI
VZkhz1wx
2uskdYDD
ZwOsqOUO
XY86UgnS
QAaUJikX
SWpVyzWB
cfN1OEXx
AQiQMb8p
3L4pZmy3
PM5G5mvl
MCPaUkV0
gcJ3kZWW
cxzVqIn5
72ZSXOJv
Z7TRVjeL
6yruqYmn
C2XK0al2
UOIckI1F
BjMRbgnW
q8Qbp8He
hotaZy8O
8b8CHU9s
ritn74wz
YXs2yR9Q
GITbEvd8
OaMiWv5k
91KZAdAg
joQXLN6f
SByqQHhm
KqjaZGuF
n8YTANv1
nGt3XZO6
IrxnBM2A
PWQ82Ao0
tB1uzhqD
SVB5KrgV
LaP5cLIN
RxA9lNsl
ME8CWENw
iuR1di6N
4QnUiekC
LXPdV1Aw
cDu5c4r0
Rro7CqKv
CFUiXnPt
3PaRtIvp
El1ipcsE
netLPJTz
mjDPBCcU
zW2CCyRG
kComvEXm
AjaTNRyU
0VYD7wF9
MwLVJnsb
7XHgCTDu
Z3Dj6i0B
b7m34T3h
ISTbPA9V
GSmBIrFB
NabZ4rxv
3rJuGOG4
uUv3VoN9
ZBAIrqjb
3pHp1Ez0
FioGdKZG
a0YiYr8y
2nixSFvW
1uiF2JPU
RH0ojsKJ
xoXROEBU
pzFEUW0W
nML4dhQO
35S59pd4
gOQvioJc
FgHzDuZC
PI2k6TuE
Ls9n9UFJ
kJjs6awl
VrDsIjh7
M5BpeYxr
HcMPY9Sp
ySe0jM7E
mjgY8xTw
hZPDHu1i
lFHahyqU
FSLGXtxv
3YuxT0qq
ua1Lobze
GyRVBBnJ
Ev0pbxK4
R0nPuvS8
XbkEh29S
q7XWqGbC
T8CqbD6a
Xfcso3Mo
0WYkFQLD
tFZU3elw
efRIYDNw
m2orm63K
GpUcF1e5
igSgVERf
zDBe0EHt
TP7409kh
IEjhweB1
gchDXWno
84QjQPuw
sYNxXh4z
EjHAkYMy
MQVhxp9A
PRGMTXOh
mT2m6Giz
jjE47mNb
1w8H1yFH
QUHM87bK
EcrBdXaY
YP5AkwSp
9dZU1R3a
GJZe6T6L
zhCCGFXk
cunsmazA
UyLvH15D
vUwcyH5I
14aIKBh9
VHFvyLKa
HiLWPb4h
CMqzJ9ZH
aqgs7Wsy
UVYsiWJ5
W67JYqiP
lM5GgWiU
Lkn7wBIb
UY0qc90L
HG3vtWKO
EJONNsyb
ua2cYqTL
nKq1bEt6
bOiHnS29
EObOrdQt
pZMTcL99
jlHhcRW6
ZFAOCJaC
Qk87ms7x
1FV88SPM
N5gvGAdv
NH1wMS7g
EBsm9I82
I3L6DF5t
dK5G4VMh
4aVD1IRg
MDMRRHrX
3a4MV6uX
XLamm7ss
YxHrnB8f
e4R1Q7lu
Nbu8eca1
vJD5S5Li
PflifLKn
AFaORB75
IdN0IehM
L85ELZ0t
53FbNGQw
tftD59Nn
kjDEQfgb
dIHu2T8z
RFzfhM8U
Z0KFwJKG
DRCA4l3s
PyfbFh0K
xXVauxbV
3OHMLtOA
naNugGAm
rUCTRbp1
30tKoPVq
UuhfXk8I
W92LVAVW
gQsqwP3b
ne1bGP0M
nofX2VAJ
OiGJTcAX
yZ8tC0Bu
bELfeITc
faLaDAWa
R0rD4gr4
qTFYfaDc
h5kAmXW6
PSquBxGR
WWfUOK55
FHx8mifr
zQAaSSBq
hUGRd6Gc
pvZBfcf0
zZcuYQXT
NtjCqUeu
9FZuIfFZ
OGDoXFBO
q70R3vt3
byg1EsJZ
8G8Ew8v9
y5bp1E1l
vdaOiSo2
DkqhKYnu
s6tk2wkF
wIAxjBVO
7F38SAdZ
ri9qE2Sa
hRy1cY8Y
vSVUgv87
Kcgqi5zM
XFNrXIna
MJthXju0
egXR5GsV
1MjRVQMB
bXU9eC4L
eMK4mCIR
NXQ5fUtb
7IcxRVRi
rt6aE60f
7JonZ4I4
qJU4rnGQ
rCY15NYO
JjfWGoiZ
zNXg6n9h
Z3FVyixu
Ih8GnKzQ
73inuj4R
G1QH2dqr
YNlaZqPl
d2i9yyZH
RRKjBbFW
inwb4Ix4
kwtVw0WK
TUmQfLDS
NDaujbCN
SX83BOqx
1EJokwq0
Phd641pQ
L29LwwOv
IVBfVpkQ
El5LV0SU
Esk9QlCO
r2OYBKw8
RN7cKE5M
TrjXPARz
M5DkIIKx
Wbv7LY7C
iIz00MrG
VonbO6f2
AsIfkjRG
VY8D7gpH
sI56ULuD
05VnoIVF
gqSjfEgo
oT1wITb6
2nl7xa4b
usd2Hoq6
iWp8AHXS
ROOQjQO7
AHzoe1Kz
CB2HX7eb
qjaqyOAi
oR6IBHOL
jeyzhpPY
QLIgqBNu
OKczL8qY
yu63bbEr
u8antIAT
HIsJoUIj
OtLKod8a
3fJAZy2F
0UzmlDxu
lZDQv5BB
msl4rB0R
gRKTN7pr
xbvWU8tx
e4Qh5uKV
iiBSJaKK
yFXJejuv
nYuprw8l
hkLYKzGL
gnr7ytYJ
V29eym99
0EPf0uNO
6BkJjHns
tginnyeT
P2r6jJm7
UNsaUfEh
Bi8kEnKD
kXwoWUpe
KdXLeSZs
sZKIUH67
oVqEcbPg
Mk7GNbOW
fsD5ymRF
iiQNrN6F
FTvlReb4
2FC4cmP6
JmTaCl9c
iotkSvLH
ovdBySeF
c5V30mzL
bvKxwsul
j6cC7NFV
oLCgU7C1
sR2C716A
hvmaLpKo
C4vX3DOl
VWZe8btJ
gz5yH2R3
r4KpoKRh
lWWsUSxX
38pNM0al
IWx7Wzid
poATCsyl
s8yq8Gvd
5g5aQY9h
Xu35toKG
iUKdgDYE
3USKOqjx
Vk2Mjuzk
CA5wStG6
GQEr4pEx
6HMO5FaB
GMUSCznZ
CPqXO91O
a47YBFtx
GxdyeIIf
q9uVC35B
tk0u0Ppf
XeRccPsa
NkrKQjrQ
jIjm5QTQ
gB5KLdp0
0KxiQspz
AXmyNQav
nwsCpQk8
8PxbbwLX
507bDW2O
sw1n3cmA
InCEu5au
W6gEVNs4
FcVFDnML
Xxyh9zZt
2bgyGOCn
xuR9irV0
oS7CA9Wy
x4CyQbje
VOpUEjZ8
FtHHRqON
6owNUCch
mPx6CFc4